ASCA + ANCA

Optimal result: 0.4 – 1.6 ELISA Index

Clinical Significance:

Crohn’s disease (CD) and Behçet’s syndrome (BS) have clinical similarities such as oral and gastrointestinal ulcerations, erythema nodosum, arthritis and uveitis. Patients with BS who present with gastrointestinal complaints have higher levels of ASCA than BS patients with no GI conditions. Vasculitides, associated with serum positivity for ANCAs affecting small- to medium-sized vessels, are commonly recognized as ANCA-associated vasculitis. ANCAs are detected in a number of autoimmune disorders, but are particularly associated with systemic vasculitis.

ANCA positivity has been shown in a high percentage of patients on long-term anti-thyroid medication; therefore, ANCA should be tested in patients receiving long-term anti-thyroid medications, and in patients with adverse reactions. Furthermore, patients with positive ANCA should be followed, and evaluated for definitive anti-thyroid therapy, to consider alternative treatment protocols.

ASCA and ANCA are well-established markers in inflammatory bowel disease (IBD), and both may be associated with disease phenotype.

In support of diagnosis of Ulcerative Colitis, the sensitivity and specificity of ANCA were 51% and 100%, respectively. ASCA presented sensitivity of 62% and specificity of 93% for Crohn’s disease.

Function:

Saccharomyces cerevisae, baker’s yeast, contains Chl1p, a putative helicase with human homologs (antiSaccharamyces cerevisae antibody – ASCA), which is required for DNA repair, recombination, transcriptional silencing and aging. Anti-neutrophil cytoplasmic antibodies (ANCAs) are a group of autoantibodies against antigens in the cytoplasm of neutrophil granulocytes and monocytes.

Antibodies Appear:

Behçet’s Syndrome with GI Involvement

Crohn’s Disease

Long-term use of Anti-Thyroid Medication

Ulcerative Colitis5 Vasculitis

Function:

Saccharomyces cerevisae, baker’s yeast, contains Chl1p, a putative helicase with human homologs (antiSaccharamyces cerevisae antibody – ASCA), which is required for DNA repair, recombination, transcriptional silencing and aging. Anti-neutrophil cytoplasmic antibodies (ANCAs) are a group of autoantibodies against antigens in the cytoplasm of neutrophil granulocytes and monocytes.

Antibodies Appear:

Behçet’s Syndrome with GI Involvement

Crohn’s Disease

Long-term use of Anti-Thyroid Medication

Ulcerative Colitis5 Vasculitis

Clinical Significance:

Crohn’s disease (CD) and Behçet’s syndrome (BS) have clinical similarities such as oral and gastrointestinal ulcerations, erythema nodosum, arthritis and uveitis. Patients with BS who present with gastrointestinal complaints have higher levels of ASCA than BS patients with no GI conditions. Vasculitides, associated with serum positivity for ANCAs affecting small- to medium-sized vessels, are commonly recognized as ANCA-associated vasculitis. ANCAs are detected in a number of autoimmune disorders, but are particularly associated with systemic vasculitis.

ANCA positivity has been shown in a high percentage of patients on long-term anti-thyroid medication; therefore, ANCA should be tested in patients receiving long-term anti-thyroid medications, and in patients with adverse reactions. Furthermore, patients with positive ANCA should be followed, and evaluated for definitive anti-thyroid therapy, to consider alternative treatment protocols.

ASCA and ANCA are well-established markers in inflammatory bowel disease (IBD), and both may be associated with disease phenotype.

In support of diagnosis of Ulcerative Colitis, the sensitivity and specificity of ANCA were 51% and 100%, respectively. ASCA presented sensitivity of 62% and specificity of 93% for Crohn’s disease.

References:

1. Fresko, et al. Anti-Saccharomyces cerevisae antibodies (ASCA) in Behçet’s syndrome. Clin Exp Rheumatol, 2005; 23(Suppl.38):S67-S70.

2. Gómez-Puerta, et al. Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease. Chest, 2009; 136:1011-1111.

3. Gunton, et al. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol, 2000; 142:587-590.

4. Lindberg, et al. Antibody (IgG, IgA, and IgM) to baker’s yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut, 1992; 33(7):909–913.

5. Nisihara, et al. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease. Dig Dis Sci, 2010; 55(8):2309-2315.

6. Seibold, et al. pANCA represents a cross-reactivity to enteric bacterial antigens. J Clin Immunol, 1998; 18(2):153-160.

ASCA + ANCA
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond ASCA + ANCA — 10,000+ markers explained
One ASCA + ANCA result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro